Overview
-
Welcome to Multibagg AI
Log in to access personalized features
Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
₹22.61
▼ 0.09
(0.41%)
| Instrument Name | Watchlist | Investment Date | % Holding | No of Units | Value (₹ Cr) | Asset Type | Industry Name |
|---|---|---|---|---|---|---|---|
 Divis Laboratories Ltd | 31 Aug 2026 | 9.54% | 3,33,687 | ₹315.90 Cr | Equity | Pharmaceuticals | |
 Sun Pharmaceutical ... | 31 Aug 2026 | 8.94% | 14,91,549 | ₹296.04 Cr | Equity | Pharmaceuticals | |
 Torrent Pharmaceuti... | 31 Aug 2026 | 4.08% | 2,66,486 | ₹135.00 Cr | Equity | Pharmaceuticals | |
 Max Healthcare Inst... | 31 Aug 2026 | 4.06% | 12,88,696 | ₹134.30 Cr | Equity | Healthcare | |
 Lupin Ltd | 31 Aug 2026 | 4.04% | 6,11,505 | ₹133.82 Cr | Equity | Pharmaceuticals | |
 Cipla Ltd | 31 Aug 2026 | 3.94% | 9,25,035 | ₹130.36 Cr | Equity | Pharmaceuticals | |
 Aster DM Quality Ca... | 31 Aug 2026 | 3.84% | 16,81,027 | ₹127.09 Cr | Equity | Healthcare | |
 Neuland Laboratorie... | 31 Aug 2026 | 3.70% | 53,164 | ₹122.33 Cr | Equity | Pharmaceuticals | |
| Anthem Biosciences Ltd | 31 Aug 2026 | 3.48% | 12,91,629 | ₹115.35 Cr | Equity | Pharmaceuticals | |
| Acutaas Chemicals Ltd | 31 Aug 2026 | 3.24% | 3,39,010 | ₹107.15 Cr | Equity | Pharmaceuticals |
Funds in the same category by AUM
You can invest in HDFC Pharma and Healthcare Fund - Direct (G) through a lump sum investment or a monthly SIP. The minimum lump sum investment is ₹100 and the minimum SIP amount is ₹100.
The latest NAV of HDFC Pharma and Healthcare Fund - Direct (G) is ₹22.61.
HDFC Pharma and Healthcare Fund - Direct (G) manages assets worth ₹3,310.64 Cr.
The expense ratio of HDFC Pharma and Healthcare Fund - Direct (G) is 1.08%.
The exit load applicable on HDFC Pharma and Healthcare Fund - Direct (G) is In respect of each purchase/Switch-in of units, an Exit load of 1% is payable if units are redeemed/switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switched-out after 30 days from the date of allotment..
As per the riskometer, HDFC Pharma and Healthcare Fund - Direct (G) carries Very High risk.
HDFC Pharma and Healthcare Fund - Direct (G) is managed by HDFC Mutual Fund.
HDFC Pharma and Healthcare Fund - Direct (G) belongs to the Sectoral Fund category.
HDFC Pharma and Healthcare Fund - Direct (G) is benchmarked against the BSE Healthcare TRI.
HDFC Pharma and Healthcare Fund - Direct (G) has no lock-in period, so units can be redeemed at any time subject to the applicable exit load.
HDFC Pharma and Healthcare Fund - Direct (G) was launched on 04 Oct 2023.
After the initial investment, you can invest in HDFC Pharma and Healthcare Fund - Direct (G) in further multiples of ₹100.
To provide long-term capital appreciation by investing predominantly in equity and equity related s securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.
To provide long-term capital appreciation by investing predominantly in equity and equity related s securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.
04 Oct 2023
₹3,310.64 Cr
₹22.61
₹100
₹100
Very High
1.08%
24.17
0.66
1.58
4.68
0.54
0.17
34.76
In respect of each purchase/Switch-in of units, an Exit load of 1% is payable if units are redeemed/switched-out within 30 days from the date of allotment. No Exit Load is payable if units are redeemed / switched-out after 30 days from the date of allotment.
| Fund | 1Y | 3Y | Expense Ratio | Fund Size | Alpha | Sharpe | Risk | |
|---|---|---|---|---|---|---|---|---|
 SBI Healthcare Opportunities ... | 22.78% | 24.99% | 1.04% | ₹5,796.42 Cr | 17.41 | 1.27 | Very High | |
 Mirae Asset Healthcare Fund -... | 22.11% | 24.02% | 0.61% | ₹3,555.18 Cr | 16.80 | 1.10 | Very High | |
| HDFC Pharma and Healthcare Fu... | 28.36% | — | 1.08% | ₹3,310.64 Cr | 24.17 | 1.58 | Very High | |
 UTI-Healthcare Fund - Direct (G) | 18.79% | 25.04% | 1.26% | ₹1,443.57 Cr | 17.68 | 1.17 | Very High | |
 Aditya Birla SL Pharma & Heal... | 19.32% | 22.43% | 1.02% | ₹1,102.73 Cr | 16.00 | 1.10 | Very High | |
 WhiteOak Capital Pharma and H... | 24.81% | — | 1.13% | ₹902.24 Cr | 19.86 | 1.14 | Very High | |
 Bandhan Healthcare Fund - Dir... | — | — | 1.22% | ₹331.57 Cr | 27.96 | 0.92 | Very High |
This fund has Very High risk.
Returns over a year are annualised (per year, compounded).
Calendar year return from the first period shown through each year.
| Company | Watchlist | Sector | Activity | Investment Date | % Holding | Market Value | Shares | Asset Type | Rating |
|---|---|---|---|---|---|---|---|---|---|
| Molbio Diagnostics Ltd | Medical Equipment | Bought | 31 Aug 2026 | 1.77% | ₹58.44 Cr | 5,38,006 | Equity | EQUITY | |
| Symbiotec Pharmalab... | Pharmaceuticals -... | Bought | 31 Aug 2026 | 1.21% | ₹40.00 Cr | 4,04,865 | Equity | EQUITY | |
| Torrent Pharmaceuti... | Pharmaceuticals -... | Bought | 31 Jul 2026 | 2.28% | ₹67.11 Cr | 1,31,000 | Equity | EQUITY | |
| Apollo Hospitals En... | Hospitals / Medic... | Bought | 31 Jul 2026 | 1.58% | ₹46.31 Cr | 51,700 | Equity | EQUITY |
Funds in the same category by AUM
| Fund | Watchlist | AMC | NAV | Fund Size | Expense Ratio | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|
 ICICI Pru Technology Fund... | ICICI Prudential Mutual Fund | ₹194.12 | ₹13,660.98 Cr | 1.22% | -11.08% | 4.46% | 1.93% | |
| HDFC Defence Fund - Direc... | HDFC Mutual Fund | ₹31.08 | ₹11,477.59 Cr | 0.89% | 23.83% | 38.03% | — | |
| ICICI Pru Banking & Finan... | ICICI Prudential Mutual Fund | ₹145.07 | ₹11,330.58 Cr | 1.23% | -3.67% | 9.21% | 8.98% | |
| SBI Banking & Financial S... | SBI Mutual Fund | ₹47.70 | ₹10,872.95 Cr | 1.20% | -0.70% | 14.93% | 11.76% | |
 Tata Digital India Fund -... | Tata Mutual Fund | ₹46.47 | ₹10,322.02 Cr | 0.67% | -13.66% | 3.50% | 1.77% | |
| HDFC Pharma and Healthcar... | HDFC Mutual Fund | ₹22.61 | ₹3,310.64 Cr | 1.08% | 28.36% | — | — |